Clinical trial

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment

NCT00280969

Study summary

ClinicalTrials.gov

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention atazanavir arm Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record efavirenz Normalized identity: efavirenz View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-09-01

PhasePHASE3

Conditions

HIV Infectionverified · MONDO: HIV infectious disease

Interventions

atazanavir armDRUG

efavirenzDRUG · verified · RxNorm: efavirenz

Sponsors & collaborators

International Medical Center of Japanlead sponsor

Ministry of Health, Labour and Welfare, Japancollaborator

Mapped research locations

ShinjukuTokyo, Japan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00280969 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.